Success Metrics

Completion Rate

0%(0/1)

Active Trials

5(71%)

Terminated

1(14%)

Phase Distribution

Ph early_phase_1

14%

Ph phase_2

29%

Ph phase_1

14%

Ph phase_3

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

2(40.0%)

Phase 3Large-scale testing

1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Terminated(2)

Detailed Status

Recruiting4

Terminated1

Active, not recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 3

Trials by Phase

Early Phase 11 (20.0%)

Phase 11 (20.0%)

Phase 22 (40.0%)

Phase 31 (20.0%)

Trials by Status

recruiting457%

terminated114%

active_not_recruiting114%

withdrawn114%

Recent Activity

5 active trials

Showing 5 of 7

active_not_recruitingphase_3

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

NCT06233903

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT04724369Phase 3

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

Active Not Recruiting

NCT07176286Phase 2

18F-mFBG Cardiac Uptake With Lewy Body Dementia

Recruiting

NCT06852807

18F-mFBG PET Imaging in the Evaluation of Neuroblastoma

Recruiting

NCT06813742

18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma

Recruiting

NCT06233903Phase 2

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Withdrawn

NCT05069220Early Phase 1

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Recruiting

NCT04258592Phase 1

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Terminated

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7